https://pubmed.ncbi.nlm.nih.gov/38117060
The cytomegalovirus protein UL38 disrupts the normal regulation of fatty acid synthesis in response to glucose availability, making infected cells vulnerable to glucose starvation.
https://pubmed.ncbi.nlm.nih.gov/38117059
Scientists have discovered a single-domain antibody that neutralizes human metapneumovirus by targeting the fusion protein’s trimer interface, providing a potential basis for future antiviral treatments.
https://pubmed.ncbi.nlm.nih.gov/38117058
This study describes the development of genetic tools for Sporomusa ovata, which will help understand its unique abilities for autotrophic biotechnologies and enable the creation of efficient recombinant strains for producing a wider range of products.
https://pubmed.ncbi.nlm.nih.gov/38117057
This study suggests that cyanobacterial blooms in wastewater treatment facilities may be endogenously seeded from benthic microorganisms, with implications for monitoring and management strategies.
https://pubmed.ncbi.nlm.nih.gov/38117056
Shewanella oneidensis MR-1 can sustainably produce industrially relevant chemicals using a cathode in a MES system without the need for phototrophic energy, highlighting the importance of understanding bacterial energy requirements and bioelectrochemical system design.
https://pubmed.ncbi.nlm.nih.gov/38117055
The newly emerged epizootic hemorrhagic disease virus serotype 8 (EHDV-8) causes infection in cattle, sheep, and goats, with sheep potentially playing a role in its epidemiology, according to a study in Italy and Tunisia.
https://pubmed.ncbi.nlm.nih.gov/38117054
Scientists have created a database called Toxinome, which contains nearly two million bacterial toxins and antitoxins from 59,475 bacterial genomes, providing a valuable resource for researching toxin biology and evolution.
https://pubmed.ncbi.nlm.nih.gov/38117051
This multicenter study investigates the use of a new bioresorbable copolyester nerve capping device for the surgical treatment of symptomatic end-neuromas, finding it to be a promising option with no declared conflicts of interest or sources of funding.